Status:
RECRUITING
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Lead Sponsor:
Kyverna Therapeutics
Conditions:
Refractory Lupus Nephritis
Myasthaenia Gravis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this long-term follow-up (LTFU) study is to collect delayed adverse events (AEs) and understand the persistence of KYV-101 (autologous CAR T cell product; gene-modified product), in par...
Eligibility Criteria
Inclusion Criteria:
- Provided informed consent for the LTFU study
- Received at least 1 infusion of KYV-101 as part of a previous KYV-101 parent treatment protocol
Exclusion Criteria:
- Not applicable
Key Trial Info
Start Date :
November 24 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2041
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT07403188
Start Date
November 24 2025
End Date
January 1 2041
Last Update
February 11 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado, Denver
Denver, Colorado, United States, 80045